Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens

Completed · Not applicable

Conditions studied: Uterine Cervical Neoplasms

In brief

The purpose of the study is to compare the results of the Becton Dickinson (BD) Onclarity™ Human Papilloma Virus (HPV) Assay on the BD Viper™ LT instrument from liquid-based cytology (LBC) media diluted in BD HPV LBC diluent to adjudicated histology results from biopsy and a molecular composite comparator.

Key facts

Study ID
NCT01944722
Run by
Becton, Dickinson and Company
People needed
33858
Starts
2013-08-01
Expected to finish
2016-03-01
Last updated by the study team
2018-06-12

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.